HCA
HCA Healthcare, Inc
HCA Healthcare, Inc historical holders
total: 11
Egerton Capital HCA Healthcare, Inc transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2014 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2014 Q4
John Armitage has been an institutional investor in HCA Healthcare, Inc (HCA) since 2014 Q3. According to 2026 Q2 report, John Armitage doesn't hold any shares. The fund/company first acquired HCA in 2014 Q3, initially purchasing about 1.27M shares. Since the initial investment, Egerton Capital has made 1 more transaction in this position.
When did John Armitage exit their HCA position?
John Armitage no longer holds HCA Healthcare, Inc (HCA). They sold off their entire position in 2014 Q4, closing out an investment that began in 2014 Q3.
When did John Armitage first invest in HCA?
John Armitage first invested in HCA Healthcare, Inc (HCA) in 2014 Q3 at the reported quarter-end price of $70.52 per share, acquiring 1,269,298 shares in their initial purchase.
What is John Armitage's average cost basis for HCA?
Based on historical transaction data, John Armitage's estimated cost basis for HCA Healthcare, Inc (HCA) is approximately $70.52 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $70.52
- Weighted AVG sell price:
- $70.52
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.